Zimmer Biomet Holdings Financials

Zimmer Biomet Holdings Inc

ZBHNYSE

Trade with Public

$98.07

-0.85-0.86%

近くで: Sep 4, 5:00 PM EST

$98.49

0.420.43%

時間外: 5:22 PM EST

概要ニュース業績予想イベント目標株価財務センチメント株主構成配当比較オプション株式レポート

Zimmer Biomet Holdings Financials

Zimmer Biomet Holdings (ZBH) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Zimmer Biomet Holdings Raises FY2026 Adj EPS Guidance from $8.40-$8.55 to $8.47-$8.59 vs $8.48 Est; Raises FY2026 Sales Guidance from $8.437B-$8.602B to $8.553B-$8.635B vs $8.544B Est

Zimmer Biomet Holdings (NYSE:ZBH) raises FY2026 Adj EPS guidance from $8.40-$8.55 to $8.47-$8.59 vs $8.48 analyst estimate. Raises FY2026 sales outlook from $8.437 billion-$8.602 billion to $8.553 billion-$8.635 billion

Benzinga Newsdesk

PRO
Zimmer Biomet Holdings Q2 Adj. EPS $2.07 Beats $2.01 Estimate, Sales $2.177B Beat $2.134B Estimate

Zimmer Biomet Holdings (NYSE:ZBH) reported quarterly earnings of $2.07 per share which beat the analyst consensus estimate of $2.01 by 2.99 percent. This is unchanged from the same period last year. The company

Benzinga Newsdesk

Jim Cramer Warns This Market Is Far More Brutal Than Dot-Com Bubble Era: 'The Difference Between Now And 1999 Is...'

Jim Cramer says investors are aggressively favoring AI stocks while heavily punishing companies that disappoint Wall Street.

Tanya Rawat

These Analysts Slash Their Forecasts On Zimmer Biomet Following Q1 Results

Zimmer Biomet Holdings, Inc (NYSE:ZBH) reported strong Q1 earnings, beating estimates and raising guidance. Analysts maintain mixed views on stock.

Avi Kapoor

Tariffs Benefit, CFO Exit: What's Going On With Zimmer Biomet Stock On Tuesday?

Zimmer Biomet raises guidance, flags tariff benefit, names interim CFO, and outlines timeline for AI-driven robotic system rollout.

Vandana Singh

Earnings Scheduled For April 28, 2026

Benzinga Insights

Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings Financials

Earnings & Guidance News

PRO
Zimmer Biomet Holdings Raises FY2026 Adj EPS Guidance from $8.40-$8.55 to $8.47-$8.59 vs $8.48 Est; Raises FY2026 Sales Guidance from $8.437B-$8.602B to $8.553B-$8.635B vs $8.544B Est

PRO
Zimmer Biomet Holdings Q2 Adj. EPS $2.07 Beats $2.01 Estimate, Sales $2.177B Beat $2.134B Estimate

Jim Cramer Warns This Market Is Far More Brutal Than Dot-Com Bubble Era: 'The Difference Between Now And 1999 Is...'

These Analysts Slash Their Forecasts On Zimmer Biomet Following Q1 Results

Tariffs Benefit, CFO Exit: What's Going On With Zimmer Biomet Stock On Tuesday?

Earnings Scheduled For April 28, 2026

ニュース

パートナーシップ

ベンジンガ・グローバル

Benzinga

Benzinga

Benzinga

Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings Financials

Earnings & Guidance News

PROZimmer Biomet Holdings Raises FY2026 Adj EPS Guidance from $8.40-$8.55 to $8.47-$8.59 vs $8.48 Est; Raises FY2026 Sales Guidance from $8.437B-$8.602B to $8.553B-$8.635B vs $8.544B Est

PROZimmer Biomet Holdings Q2 Adj. EPS $2.07 Beats $2.01 Estimate, Sales $2.177B Beat $2.134B Estimate

Jim Cramer Warns This Market Is Far More Brutal Than Dot-Com Bubble Era: 'The Difference Between Now And 1999 Is...'

These Analysts Slash Their Forecasts On Zimmer Biomet Following Q1 Results

Tariffs Benefit, CFO Exit: What's Going On With Zimmer Biomet Stock On Tuesday?

Earnings Scheduled For April 28, 2026

Benzinga

ニュース

パートナーシップ

ベンジンガ・グローバル

PRO
Zimmer Biomet Holdings Raises FY2026 Adj EPS Guidance from $8.40-$8.55 to $8.47-$8.59 vs $8.48 Est; Raises FY2026 Sales Guidance from $8.437B-$8.602B to $8.553B-$8.635B vs $8.544B Est

PRO
Zimmer Biomet Holdings Q2 Adj. EPS $2.07 Beats $2.01 Estimate, Sales $2.177B Beat $2.134B Estimate